Developing in vitro and in vivo systems to more closely model myelodysplasia and leukemia for therapeutic discovery.
A Postdoctoral Research Fellow in the Stem Cell Program, Hematology/Oncology Division, in the Department of Pediatrics, Boston Children's Hospital; Harvard Medical School. Ph.D. graduate in Biomedical Engineering from Duke University with 7+ years of research experience with strong expertise in cell and tissue culture, engineering human iPS cells, directed differentiation of human iPS cells towards mature cell types, epifluorescence, and confocal microscopy, ELISA, Western Blot, CRISPR-Cas9 genome engineering, and personalized organ on a chip and organoids handling. Awarded the NIH T32 NRSA/Lew's Fellowship, 2023 NIH T32 CBTE Outstanding Research Achievement Award, Excellence in Science award by the American Association for the Advancement of Science (AAAS)/Science Program, and Duke Scholars in Molecular Medicine (DSMM) Fellowship from Duke Clinical and Translational Science Institute (CTSI). Trained and mentored undergraduates (Huang Fellows), a junior graduate student (Dean's Research fellow), and research staff on technical assays related to laboratory research. Proven track record of handling multiple high-risk tasks in parallel with internal and external collaborators. Efficient communication skills to work in a multi-disciplinary environment. Presented works at leading conferences, including Gordon Research Conference (GRC), Cell Symposium, Keystone Symposium, TERMIS-EU, and ISSCR; works have been highlighted by the FORBES, EurekAlert AAAS, and served as a discussion leader at a Gordon Research Conference.

ORCID ID

http://orcid.org/0000-0002-3663-9311

Reviewer Keywords

developmental anomalies developmental biology drug delivery drug discovery hematopoetic stem cell hematopoiesis hematopoietic stem cell transplant high-throughput sequencing kidney leukemia microfluidics microfluidic technology organ bioengineering public health single cell sequencing stem cell zebrafish